Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety trial of Fluenz nasal spray in children aged 12 to 23 months
ISRCTN28027532Phase 2Active, not recruiting
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Aug 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Medically attended wheeze. Started Aug 2025; status: active, not recruiting.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on ISRCTN28027532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN28027532.